See more : AMS Public Transport Holdings Limited (0077.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Petlife Pharmaceuticals, Inc. (PTLF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Petlife Pharmaceuticals, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Wall Financial Corporation (WFC.TO) Income Statement Analysis – Financial Results
- Gladstone Acquisition Corporation (GLEEU) Income Statement Analysis – Financial Results
- Zix Corporation (ZIXI) Income Statement Analysis – Financial Results
- Goal Acquisitions Corp. (PUCKU) Income Statement Analysis – Financial Results
- Globus Spirits Limited (GLOBUSSPR.BO) Income Statement Analysis – Financial Results
Petlife Pharmaceuticals, Inc. (PTLF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About Petlife Pharmaceuticals, Inc.
Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injectable version for direct administration to a tumor. In addition, the company develops edible dog and cat treats. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California.
Source: https://incomestatements.info
Category: Stock Reports